Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Glioma × osimertinib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 34 Lung Neoplasms 9 Neoplasms 6 Neoplasm Metastasis 5 Carcinoma 5 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thoracic Neoplasms 1 Stage IB-IIIA Non-small Cell Lung Carcinoma 1 Skin Neoplasms 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Noonan Syndrome 1 Non Small Cell Lung Cancer Metastatic 1 Neoplasms, Squamous Cell 1 Neoplasms by Site 1 NSCLC 1 Multiple Myeloma 1 Lymphoma 1 Lung Diseases 1 Locally Advanced or Metastatic EGFR T790M+ NSCLC 1 Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer 1 Hematologic Neoplasms 1 Gastrointestinal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Squamous Cell 1 Bronchial Neoplasms 1

Interventions

Temozolomide 47 Bevacizumab 41 Radiotherapy 17 Magnetic Resonance Spectroscopy 14 Irinotecan 11 Nivolumab 8 Everolimus 7 Radiation 6 X-Rays 5 Phantoms, Imaging 5 Carboplatin 5 poly ICLC 4 pembrolizumab 4 fluorodopa F 18 4 Specimen Handling 4 Nuclear Medicine Department, Hospital 4 Erlotinib Hydrochloride 4 Carmustine 4 ribociclib 3 palbociclib 3 ivosidenib 3 antineoplaston A10 3 Vorinostat 3 Radiotherapy, Intensity-Modulated 3 Radiosurgery 3 Modafinil 3 Lomustine 3 Granulocyte-Macrophage Colony-Stimulating Factor 3 Biopsy 3 veliparib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡